CompletedNot Applicable

Ultrasonographic Guided Treatment of Acute Achilles Tendon Rupture. Evaluation of Two Novel Ultrasonographic Measurements

Denmark130 participantsStarted 2014-02

Plain-language summary

With this project the investigators wish to: 1. Test the reproducibility of Amlang's ultrasound classification by examining the intra- and inter-rater reliability. 2. Investigate whether Amlang's ultrasound classification is able to predict which patients are likely to develop complications when treated non-operatively. 3. Investigate whether Barfod's length measurement is able to predict which patients are likely to develop complications when treated non-operatively.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-70 years. * The patient must be expected to be able to attend rehabilitation and post-examinations. * The patient must be able to speak and understand Danish. * The patient must be able to give informed consent. Exclusion Criteria: * Former rupture of one or both Achilles tendon(s). * Previous surgery on the Achilles tendon. * Fluoroquinolone treatment within the last 6 months. * Tendinosis treated with corticosteroids (tablets or injections) within the last 6 months. * The patient has been diagnosed with arterial insufficiency in the legs. * Terminal illness or severe medical illness: ASA score higher than or equal to 3. * The space between the rupture and the calcaneus is less than 1cm.

What they're measuring

Corelation between Amlangs ultrasound classification or Barfods length meassure and ATRS

Timeframe: 1 year

Trial details

NCT IDNCT02062567

SponsorHvidovre University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-01

View on ClinicalTrials.gov More Achilles Tendon trials